SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-179820
Filing Date
2017-05-23
Accepted
2017-05-23 17:11:56
Documents
3
Period of Report
2017-05-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d383029d8k.htm 8-K 21780
2 EX-99.1 d383029dex991.htm EX-99.1 7376
3 GRAPHIC g383029g92z11.gif GRAPHIC 4103
  Complete submission text file 0001193125-17-179820.txt   36059
Mailing Address 400 TOTTEN POND ROAD SUITE 110 WALTHAM MA 02451
Business Address 400 TOTTEN POND ROAD SUITE 110 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 17864621
SIC: 2834 Pharmaceutical Preparations